MOLECULAR IMAGING & ANALYSIS WORKSHOP The potential that Molecular Imaging has on drug development and healthcare outcomes is well recognized. The workshop will explore: The multiple modalities available in preclinical and clinical arenas Addressing the future of bioimaging as well as imaging biomarkers The translational challenges across therapeutic areas The differences and issues with Imaging identified across the continuum from research to clinical The technologies available and in design that will help manage the mounds of data that must be converted to solid, understandable information  KEYNOTE Dr. Jeffrey L. Evelhoch is vice president, Early Stage Development and head, Imaging at Merck Research Laboratories (MRL).  In this role Jeff, provides leadership and coordination for the use of Preclinical and Clinical Imaging resources for all MRL franchises and functions.  He ensures that imaging biomarkers are used optimally in the Target through IIB space and in late stage development to help advance Merck's compounds through to registration.  Dr. Evelhoch joined Merck in 2008, after four years at Amgen as executive director, Medical Sciences and head, Imaging Sciences.  He also worked at Pfizer Global Research & Development and Pharmacia Corporation and was on the faculty of Wayne State University School of Medicine for 18 years, where he was a professor of Internal Medicine, Radiology and Cancer Biology.  Dr. Evelhoch was named a Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM) in 2003.  He is actively involved in the joint efforts of professional organizations, industry groups and federal agencies to further the development and use of quantitative imaging, including The Biomarker Consortium, the Quantitative Imaging Biomarker Alliance and the ISMRM Ad Hoc Committee on Standards for Quantitative Magnetic Resonance.  Dr. Evelhoch has a B.S. in chemistry from West Chester University and received his Ph.D. and M.S. in analytical chemistry from the University of California at Riverside.  He was also a postdoctoral fellow at Washington University in St. Louis. Throughout his career, he has actively published and served on National Institutes of Health review committees; he is currently a member of the National Cancer Institute's Experimental Therapeutics (NExT) Special Emphasis Panel.  DATE: April 26, 2010 TIME: 9:00AM-4:00PM LOCATION: Normandy Farm, Blue Bell, PA INCLUDES: Continental Breakfast, Lunch & Networking Reception Speakers Representing: University of Pennsylvania School of Medicine Merck GE Healthcare GSK NETWORKING PARTY You are all invited! Face to Face Networking- an old concept that works! Join us from 5:00-6:30pm Monday, April 26th Normandy Farm, Blue Bell, PA Free for attendees of both the Molecular Imaging Workshop & Career Transitions. $10 for all others. Networking proceeds donated to the Kortney Rose Foundation benefitting the Children's Hospital of Philadelphia. Learn more about our Career WorkshopTools for Transition: Evolving Beyond the Lab This special one-day workshop will be held in conjunction with the Molecular Imaging & Analysis Event. The BioPharma Research Council is a non-profit association formed in early January 2010. Our objective is to provide educational resources to the scientific community. We believe that scientific discourse and debate is central to the research and development process and yet many organizations have had to slash their travel and professional development budgets. We hope to fill the void left by budget cuts, and provide a local forum for NJ and PA scientists to meet and share ideas on a broad variety of topics affecting the BioPharma industry.